Home » Novartis Bids $470 Million for US Cancer Diagnostic Firm
Novartis Bids $470 Million for US Cancer Diagnostic Firm
Swiss drug maker Novartis AG said Monday it is paying $470 million to acquire U.S. cancer diagnostic specialist Genoptix Inc.
TheSunNews
TheSunNews
Upcoming Events
-
07May
-
14May
-
30May